These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35209123)

  • 1. The Role of Lipids in Allosteric Modulation of Dopamine D
    Żuk J; Bartuzi D; Miszta P; Kaczor AA
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of dopamine D
    Żuk J; Bartuzi D; Silva AG; Pitucha M; Koszła O; Wróbel TM; Matosiuk D; Castro M; Kaczor AA
    Pharmacol Rep; 2022 Apr; 74(2):406-424. PubMed ID: 35064921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential Coupling of Dopamine D
    Żuk J; Bartuzi D; Matosiuk D; Kaczor AA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Modulators of Dopamine D
    Kaczor AA; Wróbel TM; Bartuzi D
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomerization and cooperativity in GPCRs from the perspective of the angiotensin AT1 and dopamine D2 receptors.
    Durdagi S; Erol I; Salmas RE; Aksoydan B; Kantarcioglu I
    Neurosci Lett; 2019 May; 700():30-37. PubMed ID: 29684528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The action of a negative allosteric modulator at the dopamine D
    Draper-Joyce CJ; Verma RK; Michino M; Shonberg J; Kopinathan A; Klein Herenbrink C; Scammells PJ; Capuano B; Abramyan AM; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR
    Sci Rep; 2018 Jan; 8(1):1208. PubMed ID: 29352161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane.
    Yin J; Chen KM; Clark MJ; Hijazi M; Kumari P; Bai XC; Sunahara RK; Barth P; Rosenbaum DM
    Nature; 2020 Aug; 584(7819):125-129. PubMed ID: 32528175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The First Negative Allosteric Modulator for Dopamine D
    Rossi M; Fasciani I; Marampon F; Maggio R; Scarselli M
    Mol Pharmacol; 2017 Jun; 91(6):586-594. PubMed ID: 28265019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced effects of sodium ions on dopaminergic G-protein coupled receptors.
    Selent J; Sanz F; Pastor M; De Fabritiis G
    PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20711351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
    Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
    Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
    Szlenk CT; Gc JB; Natesan S
    Mol Pharmacol; 2019 Nov; 96(5):527-541. PubMed ID: 30967440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Universal 3D QSAR Model for Dopamine D
    Zięba A; Żuk J; Bartuzi D; Matosiuk D; Poso A; Kaczor AA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D
    Draper-Joyce CJ; Michino M; Verma RK; Klein Herenbrink C; Shonberg J; Kopinathan A; Scammells PJ; Capuano B; Thal DM; Javitch JA; Christopoulos A; Shi L; Lane JR
    Biochem Pharmacol; 2018 Feb; 148():315-328. PubMed ID: 29325769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the dopamine D2 allosteric modulator, PAOPA, on the expression of GRK2, arrestin-3, ERK1/2, and on receptor internalization.
    Basu D; Tian Y; Bhandari J; Jiang JR; Hui P; Johnson RL; Mishra RK
    PLoS One; 2013; 8(8):e70736. PubMed ID: 23940634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Guided Screening for Functionally Selective D
    Männel B; Jaiteh M; Zeifman A; Randakova A; Möller D; Hübner H; Gmeiner P; Carlsson J
    ACS Chem Biol; 2017 Oct; 12(10):2652-2661. PubMed ID: 28846380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
    Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.